SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-24-000246
Filing Date
2024-05-17
Accepted
2024-05-17 17:34:38
Documents
1
Period of Report
2024-05-15

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3833
  Complete submission text file 0001610717-24-000246.txt   5313
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CARA THERAPEUTICS, INC. 4 STAMFORD PLAZA, 107 ELM STREET STAMFORD CT 06902
Business Address
Mohindru Mani (Reporting) CIK: 0001664708 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37587 | Film No.: 24961536